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ABSTRACT
Objectives: To understand health disparities in
cardiovascular disease (CVD) in the indigenous M aori
of New Zealand, diagnosed and undiagnosed CVD risk
factors were compared in rural M aori in an area remote
from health services with urban M aori and non-M aori
in a city well served with health services.
Design: Prospective cohort study.
Setting: Hauora Manawa is a cohort study of
diagnosed and previously undiagnosed CVD, diabetes
and risk factors, based on random selection from
electoral rolls of the rural Wairoa District and
Christchurch City, New Zealand.
Participants: Screening clinics were attended by 252
rural M aori, 243 urban M aori and 256 urban non-
M aori, aged 20e64 years.
Main outcome measures: The study documented
personal and family medical history, blood pressure,
anthropometrics, fasting lipids, insulin, glucose,
HbA1c and urate to identify risk factors in common
and those that differ among the three communities.
Results: Mean age (SD) was 45.7 (11.5) versus 42.6
(11.2) versus 43.6 (11.5) years in rural M aori, urban
M aori and non-M aori, respectively. Age-adjusted rates of
diagnosed cardiac disease were not signiﬁcantly
d i f f e r e n ta c r o s st h ec o h o r t s( 7 . 5 %v s5 . 8 %v s2 . 8 % ,
p¼0.073). However, rural M aori had signiﬁcantly higher
levels of type-2 diabetes (10.7% vs 3.7% vs 2.4%,
p<0.001), diagnosed hypertension (25.0% vs 14.9% vs
10.7%, p<0.001), treated dyslipidaemia (15.7% vs 7.1%
vs 2.8%, p<0.001), current smoking (42.8% vs 30.5%
vs 15.2%, p<0.001) and age-adjusted body mass index
(30.7 (7.3) vs 29.1 (6.4) vs 26.1 (4.5) kg/m
2,p <0.001).
Similarly high rates of previously undocumented
elevated blood pressure (22.2% vs 23.5% vs 17.6%,
p¼0.235) and high cholesterol (42.1% vs 54.3% vs
42.2%, p¼0.008) were observed across all cohorts.
Conclusions: Supporting integrated rural healthcare
to provide screening and management of CVD risk
factors would reduce health disparities in this
indigenous population.
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ARTICLE SUMMARY
Article focus
- The indigenous M aori of New Zealand have high
rates of CVD mortality and morbidity. Current
data on the key risk factors underlying this ethnic
disparity mostly come from national surveys
relying on self-reported diagnoses or have been
collected in New Zealand’s largest urban centre,
Auckland City.
- This is the ﬁrst study to screen CVD and
associated risk factors concurrently between
rural M aori residing in an area remote from
health services (Wairoa District), urban M aori in
a city well served with secondary and tertiary
health services (Christchurch City) and an urban
non-M aori cohort.
Key messages
- We found that rural M aori had higher levels of
obesity, smoking, hypertension, dyslipidaemia,
diabetes mellitus type 2 and hyperuriaemia than
either urban M aori or non-M aori. Thus, national
health surveys and data collected in large urban
centres may signiﬁcantly underestimate the
burden of CVD risk carried by rural M aori.
- Public health initiatives to reduce rates of smoking
among rural M aori, along with enhanced imple-
mentation of CVD screening in primary care and
more intensive clinical management of hyperten-
sion, dyslipidaemia and hypeuricaemia would help
reduce cardiovascular health disparities in the
New Zealand indigenous population.
Strengths and limitations of this study
- This study was able to determine current levels of
both diagnosed and undiagnosed risk factors
within these communities by conducting CVD
screening clinics in sectors of the community that
are often hard to reach. The ﬁndings of this study
are limited by the relatively small cohort sizes and
lack of a rural non-M aori comparator cohort.
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Open Access ResearchINTRODUCTION
The indigenous M aori, comprising approximately 15%
of the New Zealand (NZ) population, have high rates of
cardiovascular disease (CVD) mortality and morbidity.
1 2
Life expectancy for M aori is less than the overall popu-
lation by 8.6 years for men and 7.9 years for women
3 and
CVD is the leading cause of death.
1 For the period
1996e1999, CVD mortality among M aori males was 3.0
times higher than that for non-M aori non-Paciﬁc males
and M aori female mortality rates were 4.2 times higher
than that for non-M aori non-Paciﬁc females.
2 Key risk
factors underlying the ethnic disparity in CVD have
recently been reported in Auckland City, New Zealand’s
largest urban centre (population approximately 1.5
million), using data from general practice clinical data-
bases
4 and from community studies.
5e9 However, three-
quarters of M aori live outside of Auckland
10 and nearly
16% reside in rural areas. Recent health statistics indi-
cate that ischaemic heart disease rates are higher among
those living in rural areas than in urban New
Zealanders.
11 Furthermore, rural M aori have an even
shorter life expectancy than urban M aori, with 1.5 years
difference for men and 1.2 years difference for
women,
11 greater than the urbanerural difference in the
general population of 0.8 and 0 years for men and
women, respectively.
11 Rural non-M aori do not neces-
sarily share the same levels of deprivation as rural M aori.
In areas classiﬁed as ‘Highly Rural/Remote’, almost
half (46%) of deprivation quintile ﬁve residents are
M aori.
11 No studies to date have compared cardiovas-
cular health and risk factors between rural and urban
M aori communities, and the only previous study of
cardiovascular health in rural M aori was conducted
50 years ago.
12
We have recently reported high levels of both diag-
nosed and undiagnosed CVD risk factors, especially
hypertension, dyslipidaemia and diabetes in a rural
M aori community,
13 with several major risk factors at
higher levels than those reported than either national
statistics or for Auckland City M aori. To understand how
CVD risk factors differ between diverse localities across
New Zealand, we have compared the cardiovascular risk
proﬁles of two regionally distinct rural and urban M aori
communities and a matched urban comparator cohort
of non-M aori to identify risk factors in common and
those that differ among these communities. This is the
ﬁrst study to screen CVD and associated risk factors
concurrently in rural M aori residing in an area remote
from health services and in urban M aori in a metropol-
itan area well served with secondary and tertiary health
services.
METHODS
Localities
The Hauora Manawa/Community Heart Study is
a cohort study of heart disease in NZ, based on random
selection from electoral rolls, sampled to be represen-
tative of the age and gender proﬁles within each
participating M aori community. The intention was to
select two M aori communities as diverse from each other
as possible. The Wairoa District is located in rural
Hawkes Bay on the North Island of NZ with a population
in 2006 of 8481 of whom 61% identiﬁed as M aori
ethnicity. It is located 2 h north by road of the nearest,
fully serviced hospital. Using the Statistics New Zealand
deﬁnition of rural that uses workplace area meshblocks
to allocate a district to one of four categories,
14 based on
employment location as the deﬁning variable, Wairoa
District is classiﬁed in part ‘Rural Area with Low Urban
Inﬂuence’ and part ‘Highly Rural//Remote Area.’
Wairoa is one of three regions in New Zealand where
M aori make up over 60% of the local population.
15 The
district has associated socioeconomic deprivation and
issues of healthcare access. M aori in Wairoa have
a median income of $18500 (compared with a median
of $20900 for all M aori and $24400 for all of New
Zealand).
15 A matched non-M aori sample was not
recruited from the small non-M aori population because
of differing demographics between the two ethnic
groups, especially the younger population proﬁle of
M aori. Operating under the umbrella of the Hawkes Bay
District Health Board, which also manages the local
hospital situated in the city of Hastings, primary
healthcare in Wairoa at the time of the study consisted of
four general medical practices, all located within Wairoa
township and administered by a single Primary Health-
care Organisation. In addition, there were four M aori
health providers across the Wairoa District, providing
health support services.
In contrast, Christchurch is the largest city in the
South Island with a population in 2006 of 348435, of
whom 7.6% identiﬁed as M aori and 75.4% identiﬁed as
New Zealand European. Christchurch City has a large
(600e650 bed) tertiary, teaching and research hospital
that provides a full range of emergency, acute, elective
and outpatient services. Socioeconomic differences
between the M aori and non-M aori urban populations
were not so marked, with median income levels for
M aori being $22000 versus $23400 for the Christchurch
population overall.
16 Operating under the umbrella of
the Canterbury District Health Board, primary health-
care in Christchurch City is administered by two Primary
Healthcare Organisations, with approximately 100
member general practices and 10 additional M aori
health providers.
Participants
Full details of sample selection, recruitment, inter-
viewing processes and kaupapa M aori methodology are
published elsewhere.
17 In brief, participants, aged
between 20 and 64 years, stratiﬁed by age and sex were
randomly selected from the combined general and
M aori electoral rolls for Wairoa District and for Christ-
church City (excluding Banks Peninsula Ward, a largely
rural area amalgamated with Christchurch City in 2006).
The New Zealand electoral rolls have 93.44% enrolment
of the eligible population, are updated every 3 years
18
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this study as it allowed selection of targeted age and
gender samples of speciﬁc ethnic M aori and non-M aori
descent. Participants for the M aori samples were selected
from among those who identiﬁed as being of M aori
descent on the roll and who also self-identiﬁed at
interview as being of M aori ethnicity. Since 1986, self-
identiﬁcation of ethnicity has become the standard
practice in New Zealand government, health and
research documentation,
19 20 and participants in this
study were asked the ethnicity question as in the New
Zealand Census. In the census, people can report
multiple ethnicities, and anyone listing M aori is counted
as M aori under both prioritised and total response
analyses. The Christchurch non-M aori descent selection
was frequency matched to the sex- and age-group
distribution of the Christchurch M aori descent sample.
The overall response rates were 57.6% (95% CI 53.0 to
62.2; 254/441) for the Wairoa M aori descent sample,
48.3% (95% CI 44.1 to 52.4; 267/553) for the Christ-
church M aori descent sample and 57.2% (95% CI 52.7
to 61.8; 257/449; 254/340) for the Christchurch non-
M aori descent sample. The cooperation rates rate
(participation among those with whom contact was
established) were 74.7% (95% CI 70.1 to 79.3) for the
Wairoa M aori, 66.6% (95% CI 62.0 to 71.2; 267/401) for
the Christchurch M aori and 71.4% (95% CI 66.7 to 76.1;
257/360) for the Christchurch non-M aori group.
The current study was unique in that it integrated
elements of biomedical CVD research design, such as
recruitment by random selection (not consistent with
M aori cultural processes in which tribal leaders would
select participants) within a kaupapa M aori framework.
Kaupapa Maori research provides a structure in which
M aori worldview is the norm.
21 The following aspects of
kaupapa M aori research were incorporated in the
Hauora Manawa Study: the project was M aori led and
controlled (lead investigator was Suzanne Pitama, Ngati
Kahungunu ki Wairoa); the research objectives were
based on M aori values, beliefs and experiences and were
validated by the M aori communities who were the focus
of the study; the research had to demonstrate beneﬁt to
the community; joint ownership of the data/information
was negotiated between researchers and participants/
communities; the research team was accountable to the
communities from which the information was gathered
and appropriate analysis was employed to minimise
dominant cultural biases.
The study was approved by the multi-region ethics
committee (reference MEC/06/03026), and all partici-
pants provided written informed consent.
Screening clinics
Screening clinics were held at Wairoa Hospital (May to
December 2007) or at the M aori/Indigenous Health
Institute, Christchurch, (January to December 2008), as
described previously.
13 In brief, all participants
completed an interviewer-administered questionnaire
providing demographic, personal and family medical
history, current medications, smoking status recorded as
current, ex-smoker (quit more than 12 months) or
never-smoker, alcohol consumption, physical activity
levels (physically active deﬁned as ‘at least 30 min of
moderate or vigorous physical activity on 5 or more days
of the week’) and socioeconomic data. Blood pressure
was recorded (two measurements, seated, at least 20 min
apart), height, weight, waist and hip measurements were
taken and body mass index (BMI) was calculated. Body
composition analysis was performed by bioimpedance
using the Tanita Body Composition Analyser, TBF 310
(Tanita Inc, Tokyo, Japan), and the output automatically
classiﬁed participants into healthy body fat, overweight
body fat and obese body fat ranges according to age and
gender. Fasting blood samples were collected and
assayed for full blood differential cell counts, plasma
lipid proﬁles, glucose, insulin, creatinine, homocysteine,
HbA1c and urate (Wairoa Hospital Laboratory, Hawkes
Bay District Health Board or Canterbury Health Labo-
ratories, Christchurch Hospital).
A prior cardiac history was deﬁned as a history of
diagnosed myocardial infarction, angina, heart failure,
coronary artery bypass graft surgery, percutaneous
transluminal coronary angioplasty, pacemaker, other
cardiac intervention or ischaemic stroke. Conﬁrmation
of prior diagnoses and current management of CVD risk
factors were obtained from primary care physicians for
all participants. A new diagnosis of hypertension and
dyslipidaemia was made at screening in those with levels
above the reference ranges with no prior diagnosis and
who were not receiving treatment. Hypertension was
documented if the average of the two blood pressure
readings gave a systolic blood pressure (SBP)
>140 mm Hg or diastolic blood pressure >90 mm Hg.
Dyslipidaemia was diagnosed if the total cholesterol:
high-density lipoprotein cholesterol ratio (HDL:TC) was
>4. The Bestpractice electronic decision support soft-
ware (Bestpractice, 2005e2009, Dunedin, New Zealand)
was used to calculate 5-year CVD risk scores according to
the New Zealand CVD Risk Guidelines
22 and was also
used to classify participants with metabolic syndrome at
screening.
Statistical analysis
All statistical analyses were performed using SPSS V.13.0.
Data are expressed as mean (SD) or as percentages. Data
collection was complete except for anthropometric data
for one rural participant. Logistic regression analyses
were used to compare binary outcomes across the three
cohorts and univariate analysis for continuous variables,
and both unadjusted p values and p values corrected for
age and gender are presented. Pairwise comparisons
(rural vs urban M aori; urban M aori vs urban non-M aori)
were carried out using analysis of variance or c
2 tests, as
appropriate for continuous or discrete variables,
respectively. For discrete non-binary variables, overall c
2
tests on a 333 table were used followed by a separate
233 c
2 test for each pairwise comparison. Signiﬁcance
levels were set as p#0.05.
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Baseline characteristics and prior diagnoses
The baseline characteristics of the 751 participants who
attended the screening clinics are shown in table 1.
Rural M aori participants, at a mean age of 45.7 years,
were older than both urban cohorts (42.6 years and
43.6 years). Comparisons of key risk factors contributing
to CVD risk across the three cohorts are described below.
Rates of prior cardiac history showed a non-signiﬁcant
trend to be higher in M aori than non-M aori (p¼0.073,
table 1). Although age of onset of CVD tended to be
lower in urban M aori than either of the other groups,
the differences among the three cohorts were not
signiﬁcant (51.869.8 vs 43.865.7 vs 50.268.2 years,
p¼0.539, for rural M aori, urban M aori and urban non-
M aori, respectively). A prior diagnosis of rheumatic fever
had been made in 2% of Wairoa cohort, 0% of urban
M aori and 0.4% of urban non-M aori. Of those with
a personal cardiac history, 68% of rural M aori, 100% of
urban M aori and 71% of non-M aori reported having
ﬁrst-degree family history of CVD. Overall, including
those both with and without a personal cardiac history,
the rates of ﬁrst-degree family history of CVD were 52%
rural M aori versus 58% urban M aori versus 55% non-
M aori (p¼0.401).
A prior diagnosis of hypertension was more common
in rural M aori than urban non-M aori (table 1), but not
signiﬁcantly different between the two urban groups,
and this was reﬂected in higher rates of treatment with
antihypertensive medications in rural M aori (21.4% vs
11.9% vs 8.6%, p<0.001). Mean SBP and diastolic blood
pressure levels at screening were slightly but signiﬁcantly
higher in both M aori groups compared with non-M aori
group.
Rates of previously diagnosed treated dyslipidaemia
were highest in rural M aori, followed by urban M aori
and lowest in non-M aori (table 1,p <0.0001). However,
mean values of the key cholesterol variables were above
the recommended ranges set by national cardiovascular
guidelines in all three cohorts,
22 with urban M aori
tending to have the least favourable lipid proﬁles. Urban
M aori had higher low-density lipoprotein (LDL)
cholesterol levels than rural M aori although mean levels
of TC, HDL cholesterol, triglycerides and TC:HDL ratios
did not differ between the two M aori communities.
Urban M aori also had higher triglycerides and lower
HDL cholesterol levels compared with non-M aori, while
mean levels of TC, LDL cholesterol and TC:HDL ratios
were similar between the two urban cohorts.
Plasma urate has been reported to be an independent
risk factor for CVD.
23 Plasma urate levels were signiﬁ-
cantly higher in rural M aori than urban M aori, which
were also higher than in non-M aori (table 1). Urate
levels were above the reference ranges (0.42 mmol/l in
men and 0.37 mmol/l in women) in 25% of rural M aori,
10% of urban M aori and 5% of non-M aori. Previously
diagnosed gout was reported by 6% of rural and 4% of
urban M aori and 0.4% non-M aori. Of those, 56% of
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Cardiovascular risk in rural and urban M aorirural M aori, 22% urban M aori and 0% non-M aori had
plasma urate levels above the gender-speciﬁc thresholds
at screening.
Metabolic risk factors
A prior diagnosis of diabetes mellitus type 2 (DM2)
(table 2) was signiﬁcantly more frequent in rural M aori
compared with either urban M aori or non-M aori
cohorts. In DM2 patients, 48.1% of rural M aori, 66.7% of
urban M aori and 33.3% of non-M aori with DM2 had
a ﬁrst-degree family history of DM2. Overall, including
those with and without DM2, rates of ﬁrst-degree family
history of DM2 were 43% rural M aori versus 31% urban
M aori versus 21% non-M aori (p<0.001). Metabolic
syndrome, diagnosed at screening, was signiﬁcantly
more prevalent in both rural and urban M aori than non-
M aori (table 2).
A gradient in BMI was seen across the three cohorts
(table 2), with both the age-adjusted mean BMI and the
proportion with a BMI in the obese range being greatest
in rural M aori and lowest in non-M aori. A similar
gradient was observed in per cent body fat, with more
rural M aori classiﬁed in the combined overweight and
obese per cent body fat categories and more urban
M aori than non-M aori in these categories (p<0.001). In
contrast, there was a signiﬁcantly higher mean fat-free
mass in both M aori communities compared with non-
M aori. The waist:hip ratios were slightly higher in rural
M aori than either of the two urban groups (p¼0.005 to
p<0.001). The mean levels of the diabetes risk markers
(fasting glucose, HbA1c and fasting insulin) were
signiﬁcantly higher in rural M aori than urban M aori,
remaining signiﬁcant after adjusting for gender and age
(p<0.001), with HbA1c and insulin also higher in urban
M aori than non-M aori. Inclusion of BMI into the
univariate model accounted for cohort differences in
fasting insulin levels and fasting glucose. However,
HbA1c levels, even when adjusted for age, gender and
BMI, remained signiﬁcantly higher in rural M aori than
urban M aori (p<0.001) and higher in urban M aori than
non-M aori (p<0.001).
Lifestyle risk factors
Rural M aori had the highest rate of current smoking
(table 2). In both M aori cohorts, more women were
current smokers and more men were ex-smokers;
however, there was a trend for men to have a higher
calculated number of pack-years than women across all
three cohorts. Current smokers were of similar mean age
(42.0610.5 vs 41.0610.7 vs 40.7612.5 years, p¼0.754).
Alcohol drinking was signiﬁcantly less common in
rural M aori than either urban M aori or non-M aori
(p¼0.002), but the two urban communities were similar
in their proportions of alcohol drinkers. The mean age
of current drinkers tended to be similar in all three
cohorts (rural M aori 44.5611.4 vs urban M aori
42.4611.2 years; non-M aori 43.1611.4 years, p¼0.153).
Recommended sessional drinking limits (no more than
six standard drinks per session) were reported to be
exceeded daily by 2% rural M aori, 3% urban M aori and
1% non-M aori, weekly by 26% rural M aori, 21% urban
M aori and 11% urban non-M aori and monthly or less by
55% rural M aori, 44% urban M aori and 48% non-M aori
drinkers.
Physical activity within recommended guidelines was
reported by similar proportions of rural M aori, urban
M aori and non-M aori (table 2). Physical activity was not
independently associated with any other cardiovascular
risk factors.
Almost all participants were registered with a general
practitioner at the time of screening. Similar propor-
tions of each cohort had visited their doctor within the
last 6 months (69% vs 61% vs 66%) or had visited their
doctor within the last 12 months (85% vs 74% vs 79%).
Levels of previously undiagnosed hypertension and
dyslipidaemia
At screening, approximately 20% of each community
were found to have blood pressures above the recom-
mended range (undiagnosed hypertension, table 3).
Overall, the combined rates of diagnosed and undiag-
nosed hypertension across the three cohorts were not
signiﬁcantly different between the two M aori cohorts
when adjusted for age but higher in urban M aori than in
non-M aori.
For rural M aori, key risk factors in a logistic regression
model for predicting hypertension were gender 3 age
(OR¼1.243 (95% CI 1.061 to 1.155), p<0.0001), BMI
(OR¼1.107 (95% CI 1.033 to 1.135), p<0.001), current
smoker (OR¼0.461 (95% CI 0.213 to 0.995), p¼0.049)
and family history of hypertension (OR¼2.042 (95% CI
1.178 to 3.540), p¼0.011). For urban M aori, key risk
factors for predicting hypertension were gender 3 age
(OR¼1.257 (95% CI 1.106 to 1.430), p<0.0001), an
obese % body fat, (OR¼4.394 (95% CI 2.168 to 8.907),
p<0.0001) and family history of hypertension
(OR¼1.972 (95% CI 1.074 to 3.619), p¼0.029). Among
non-M aori, the interaction of gender 3 fasting triglyc-
eride levels (OR¼1.886 (95% CI 1.366 to 2.603),
p<0.0001) and age (OR¼1.512 (95% CI 1.161 to 1.968),
p¼0.002) were the risk factors signiﬁcantly associated
with having hypertension.
New diagnoses of dyslipidaemia made at screening
(undiagnosed dyslipidaemia, table 3) were signiﬁcantly
more common in urban M aori after accounting for age
than in either rural M aori or non-M aori. Overall, when
diagnosed and undiagnosed dyslipidaemia were
combined, over half of each M aori cohort and 45% of
non-M aori cohort were dyslipidaemic.
For rural M aori, the only independent risk factor
identiﬁed in a logistic regression model for predicting
dyslipidaemia was waist circumference (OR¼1.027 (95%
CI 1.009 to 1.044), p¼0.003). In urban M aori, dyslipi-
daemia was predicted by an interaction of gender and
BMI (OR¼0.960 (95% CI 0.94 to 0.98, p<0.0001, male
gender being protective) and an inverse effect of ﬁrst-
degree family history of high cholesterol (OR¼0.55
(95% CI 0.32 to 0.96), p¼0.034). The interaction of
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Cardiovascular risk in rural and urban M aorigender 3 BMI was also identiﬁed in urban non-M aori,
associated with a protective effect in men (OR¼0.95
(95% CI 0.93 to 0.97), p<0.0001).
Five-year CVD risk scores
The calculated 5-year CVD risk scores, as published in
the New Zealand CVD Risk Guidelines
22 and stratiﬁed by
age range and gender, are shown in table 4. These scores
estimate the likelihood of having a CVD event (myocar-
dial infarction, new angina, ischaemic stroke, transient
ischaemic attack, peripheral vascular disease, congestive
heart failure and cardiovascular-related death) within
the next 5 years and are based on an algorithm including
age, gender, SBP, TC:HDL ratio, current smoker or not
and presence or absence of diabetes. In addition, the
guidelines recommend that scores for certain high-risk
population groups, including M aori be moved up one
risk category (5% added). Therefore, the two M aori
cohorts have an additional 5% making direct compari-
sons with the non-M aori group difﬁcult. Nonetheless,
table 4 shows the expected trend of increasing risk scores
across the three cohorts from rural M aori, to urban
M aori, to non-M aori in all age and gender categories
except in 60e65-year-old males, where urban M aori
males have the highest risk.
DISCUSSION
CVD is the major factor contributing to the ethnic
disparities of life expectancy between M aori and non-
M aori in NZ, and yet how key risk factors contributing to
this discrepancy vary across different localities has not
previously been described. To our knowledge, this is the
ﬁrst study to compare current levels of CVD and associ-
ated risk factors between two regionally distinct M aori
communities: rural M aori residing in an area remote
from health services and urban M aori in a city well
served with secondary and tertiary health services, as well
as non-M aori residing in the same locality. The salient
ﬁnding was a gradient of cardiovascular risk with the
highest burden of CVD risk in rural M aori, particularly
obesity, smoking, hypertension, dyslipidaemia, DM2 and
hyperuricaemia. Increased measures of body mass were
key risk factors associated with the elevated fasting
insulin and glucose levels, diagnosed hypertension and
dyslipidaemia in both M aori cohorts, but particularly
in rural M aori. However, we also observed that
Table 3 Prior and new diagnoses of cardiovascular risk factors in rural M aori, urban M aori and urban non-M aori
Rural
M aori
Urban
M aori Non-M aori
Overall,
unadjusted p
(adjusted p)
(a) vs (b),
unadjusted p
(adjusted p)
(b) vs (c),
unadjusted p
(adjusted p)
(a) vs (c),
unadjusted p
(adjusted p) (a) (b) (c)
Hypertension
Prior diagnosis
hypertension, %
25.0 14.8 10.5 <0.001 (0.001) 0.006 (0.115) 0.157 (0.061) <0.001 (<0.001)
Undiagnosed
hypertension, %
22.2 23.5 17.6 0.235 (0.124) 0.744 (0.744) 0.105 (0.054) 0.191 (0.109)
Total hypertension, % 47.2 38.3 28.1 <0.001 (<0.001) 0.045 (0.236) 0.016 (0.002) <0.001 (<0.001)
Dyslipidaemia
Prior diagnosis
dyslipidaemia, %
15.7 7.1 2.8 <0.001 (<0.001) 0.004 (0.051) 0.032 (0.007) <0.001 (<0.001)
Undiagnosed
dyslipidaemia, %
42.6 55.0 42.4 0.008 (0.004) 0.005 (0.014) 0.006 (0.002) 0.961 (0.570)
Total dyslipidaemia, % 58.2 62.2 45.6 0.001 (<0.001) 0.373 (0.261) <0.001 (<0.001) 0.005 (<0.001)
Undiagnosed ¼ no prior diagnoses or receiving treatment; total diagnoses ¼ potential + previous diagnosis; adjusted p value ¼ adjusted for age.
Table 4 Mean 5-year CVD risk scores* by age and gender in the rural Maori, urban Maori and urban non-Maori cohorts
Rural M aori CVD risk score (n) Urban M aori CVD risk score (n)
Urban non-M aori CVD risk score
(n)
Males,
N[102
Females,
N[150
All,
N[252
Males,
N[110
Females,
N[133
All,
N[243
Males,
N[125
Females,
N[131
All,
N[256
Age range (years), %
20e29 5.4 (10) 5.1 (20) 5.2 (30) 5.1 (15) 5.0 (22) 5.1 (37) 1.3 (16) 0.5 (19) 0.9 (35)
30e39 6.6 (23) 6.1 (33) 6.3 (56) 6.7 (32) 5.3 (34) 6.0 (66) 3.9 (32) 2.6 (38) 3.2 (70)
40e49 9.9 (22) 8.0 (41) 8.6 (63) 9.0 (33) 7.2 (42) 7.9 (75) 6.0 (36) 4.5 (37) 5.2 (73)
50e59 15.0 (32) 10.8 (43) 12.6 (75) 14.4 (21) 10.8 (22) 12.6 (43) 10.9 (28) 6.4 (24) 8.8 (52)
60e65 14.6 (15) 16.7 (13) 15.6 (28) 22.2 (9) 14.5 (13) 17.6 (22) 16.1 (13) 10.1 (13) 13.1 (26)
*Calculated by BestPractice software according to the New Zealand CVD Risk Guidelines
22dnote that all those of M aori ethnicity have score
adjusted upwards by 5% in the NZ CVD Risk Scores.
CVD, cardiovascular disease.
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common across all three New Zealand population
groups, despite the establishment of nationwide CVD
screening guidelines.
Findings in relation to national statistics
The 2006/2007 New Zealand Health Survey docu-
mented self-reported health information across the New
Zealand population and included analysis by ethnicity
but not by locality.
24 National prevalence rates were
comparable to levels of CVD risk factors we observed in
urban M aori but would substantially underestimate CVD
risk in rural M aori. For example, 13.6% of the national
population reported having medicated high blood
pressure,
24 similar to the 14.9% in our urban M aori but
less than the 25% in our rural M aori participants.
Nationwide, one in 12 adults (8.4%) had medicated high
cholesterol, comparable to the 7.1% in urban M aori in
the current study but less than the 15.7% in rural M aori.
The national prevalence of diagnosed DM2 was 5% in
the general population
24 and 5.8% in M aori (age
adjusted).
24 Rural M aori in the current study had double
the reported national rates of diabetes (10.7%)
compared with only 3.7% in urban M aori and 2.4% in
non-M aori. National rates of smoking remain higher in
M aori (42.2%) compared with the general New Zealand
population (19.9%).
24 In the current study, 42.8% of
rural M aori and 30.5% of urban M aori were smokers
compared with 15% of urban non-M aori. In our data,
the multivariate model predicting hypertension appears
to indicate that smoking exerts a protective effect on
hypertension in rural M aori. This apparent smoker’s
paradox, where current smokers have less hypertension
or better CVD outcomes than former or never smokers,
has been previously reported in the literature.
25 26 It has
been suggested that smoking protects against hyperten-
sion only in overweight and obese individuals, but not in
normal weight individuals,
25 which may explain why it is
more evident in the rural cohort. In the New Zealand
Health Survey, only 50.5% of adults report being physi-
cally active.
24 In the current study, around 70% of each
cohort reported being physically active, consistent with
national data reporting that M aori are at least as physi-
cally active as any other ethnic group in New Zealand.
24
It is apparent that the large BMIs and metabolic risk
factors observed among the M aori participants were not
associated with a less active lifestyle.
Plasma urate levels, an independent predictor of
CVD,
23 were above reference ranges in 25% of rural
M aori and 10% of urban M aori. The national prevalence
of gout is 1.3%, substantially lower than in the current
study, with 6% of rural M aori and 4% of urban M aori
having been diagnosed by a doctor with gout. It has been
known for some decades that gout is a common problem
in M aori and Paciﬁc Islanders
27e29 as a result of
a difference in renal urate handling.
30 Very recently, two
genetic variants have been shown to have genome-wide
signiﬁcant association with gout.
31 One of these,
a variant form of the renal urate transporter gene,
SLC2A9, has been shown to be signiﬁcantly associated
with gout in M aori and Paciﬁc Island patients.
32 Serum
urate levels may be an important underlying risk factor
in M aori and Paciﬁc people.
The estimated 5-year CVD risk scores within each age
and gender category showed a trend for increasing risk
from urban non-M aori to urban M aori and then to rural
M aori (except for men aged 60e64 years). However,
these differences were more subtle than might have
been expected, considering the differences among the
cohorts of each composite risk factor used in the CVD
risk score calculation. For example, rural M aori had
higher levels of smoking, hypertension and DM2 than
either urban M aori or non-M aori and yet the maximum
differences between the cohorts in risk scores were less
than the 5% adjustment added to those of M aori
ethnicity. This suggests that overlapping risk factors (eg,
being M aori, having long-term DM2 and having family
history of CVD, in which case 5% adjustment is applied
only once) may dampen the CVD risk score, possibly
underestimating extremes of risk observed in some
individuals. Moreover, obesity, a salient risk factor that
differed across the cohorts, is not included in the CVD
risk score algorithm. Also, small differences in the age
distributions between the rural M aori cohort and the
other two groups might limit comparisons of CVD risk
scores since the scores may not predict well for younger
individuals. The performance of the NZ risk assessment
equation in predicting 5-year CVD events, particularly
for M aori, is currently undergoing scrutiny and recon-
sideration in the published literature.
33e35 We propose
that the individual risk proﬁles may be more informative
when deciding clinical management for a speciﬁc
patient.
Findings in relation to other regional studies
The current community cohort design is comparable
with an Auckland study based on cross-sectional
sampling, the Diabetes Heart and Health Survey 2002/
2003.
5e7 In that study, 37% of M aori and 22% of others
had raised blood pressure, with 7% of M aori and 2% of
others having previously undetected high blood pres-
sure; more diagnosed but less undiagnosed hyperten-
sion than in the current study. Mean TC:HDL
cholesterol ratios were 4.32 in M aori and 4.04 in others,
comparable to our urban M aori and non-M aori cohorts.
In addition, approximately 94% of participants had
total cholesterol levels above 4 mmol/l, similar to the
current study (90.7% across all three cohorts), an
alarming proportion of each cohort with lipid proﬁles
above recommended ranges. These ﬁndings suggest
that elevated cholesterol is a key risk factor that is
widespread in the New Zealand population and could
be more intensively screened and managed throughout
primary care. The Auckland prevalence of DM2 was
12% in M aori,
9 similar rates to the rural M aori, and
3.9% in Europeans similar to both our urban cohorts.
Metabolic syndrome was identiﬁed in 32% Auckland
M aori and 16% of others.
7 This was less than in our
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cohorts (27.1% and 14.5%). In combination, these data
suggest that levels of several risk factors in rural Wairoa
M aori exceed those among M aori living in Auckland,
especially smoking, undiagnosed hypertension and
metabolic syndrome. This contrasts with prior studies
from Thailand
36 and Peru
37 that reported higher
metabolic and CVD risk factors in urban dwellers than
rural residents. However, in Australia, metabolic risk was
higher in rural patients with DM2,
38 as in the current
study.
The current ﬁndings reﬂect a previous study of meta-
bolic and cardiovascular health in a rural M aori
community of the Tuhoe tribe performed 50 years
ago.
12 39 Prior et al screened 212 Tuhoe adults living in
the isolated Ruatahuna Valley in the Urewera region.
12 39
The study highlighted high rates of coronary heart
disease, obesity, high cholesterol, hyperuricaemia, clin-
ical gout and diabetes. It is difﬁcult to compare the
speciﬁc data with the current study, as many of the
indices measured are no longer in use, such as ‘relative
weight’ and the use of skin fold measurements to assess
body fat. There was a 5% prevalence of rheumatic heart
disease, considerably higher than the 2% of rural M aori
in the current study. Rates of smoking were 59% among
men and 70% among women, also substantially higher
than we observed in the rural Wairoa cohort. However,
mean blood pressure and rates of DM2 were similar to
current Wairoa residents. From those ﬁndings, alongside
the current study, it would appear that health issues
besetting rural M aori have improved only a little over the
past half century.
Strengths and limitations of the study
This study was able to determine current levels of both
diagnosed and undiagnosed risk factors within these
communities by conducting CVD screening clinics in
sectors of the community that are often hard to reach.
Prior reports based on areal surveys (usually reliant on
self-reported diagnoses) or clinical databases may
substantially underestimate disease rates and risk factors
in indigenous population groups who may not have
equivalent access to healthcare or CVD screening. The
ﬁndings of this study are limited by the relatively small
cohort sizes, the study design being constrained by the
costs of the in-depth CVD screening. Also, the lack of
a rural non-M aori comparator cohort is a limiting factor,
resulting from the difﬁculty in achieving a matched non-
M aori sample because of the small number of non-M aori
in Wairoa and differing demographics between M aori
and non-M aori in the District. In addition, there were
slight differences in age distributions between the rural
M aori sample and the other two cohorts. While most
age-dependent measures were able to be age adjusted,
the algorithm used to calculate the CVD risk scores
includes age as a risk factor and hence could not be age
adjusted. The authors recognise that use of two blood
pressure measurements in a clinic setting is not a deﬁn-
itive diagnosis of hypertension.
In conclusion, this study reports that compared with
either urban M aori or non-M aori, there is a greater
burden of CVD risk factors, particularly obesity, hyper-
tension, dyslipidaemia, DM2, hyperuricaemia and
smoking in rural M aori, who have remained largely
unstudied for the past half-century. Moreover, the ﬁnd-
ings demonstrate that CVD risk proﬁles ascertained in
national health surveys or in New Zealand’s largest
metropolitan population do not necessarily reﬂect other
localities; Christchurch M aori appear to have lower risk
than Auckland M aori, while M aori living in rural Wairoa
have substantially higher risk. Despite two-thirds of all
three cohorts reporting visiting their primary care
physicians in the past 6e12 months, the study identiﬁed
similarly high levels of undiagnosed hypertension and
elevated cholesterol in each of the population samples.
Rural M aori participants reported similar attendance of
participants with their GPs, indicating good engagement
with primary care and suggesting that higher rates of
some risk factors among the rural contingent were
not necessarily associated with barriers to accessing
primary care. However, public health initiatives to
reduce rates of smoking among M aori, along with
enhanced implementation of CVD screening in primary
care and more support for rural general practices to
provide intensive clinical management of hypertension,
dyslipidaemia and hypeuricaemia would help reduce the
CVD health disparities in the New Zealand indigenous
population.
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